These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23889952)

  • 1. Physician follow-up and observation of guidelines in the post treatment surveillance of colorectal cancer.
    Vargas GM; Sheffield KM; Parmar AD; Han Y; Brown KM; Riall TS
    Surgery; 2013 Aug; 154(2):244-55. PubMed ID: 23889952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receipt of guideline-recommended follow-up in older colorectal cancer survivors : a population-based analysis.
    Cooper GS; Kou TD; Reynolds HL
    Cancer; 2008 Oct; 113(8):2029-37. PubMed ID: 18780338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a dedicated cancer center surveillance program on guideline adherence for patients with stage II and III colorectal cancer.
    Standeven L; Price Hiller J; Mulder K; Zhu G; Ghosh S; Spratlin JL
    Clin Colorectal Cancer; 2013 Jun; 12(2):103-12. PubMed ID: 23153862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance with ASCO guidelines for surveillance after colorectal cancer treatment: a population-based analysis.
    Sisler JJ; Seo B; Katz A; Shu E; Chateau D; Czaykowski P; Wirtzfeld D; Singh H; Turner D; Martens P
    J Oncol Pract; 2012 Jul; 8(4):e69-79. PubMed ID: 23181004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum carcinoembryonic antigen measurement, abdominal contrast-enhanced computed tomography, and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of colorectal cancer recurrence: a correlative study.
    Ozkan E; Soydal C; Araz M; Aras G
    Nucl Med Commun; 2012 Sep; 33(9):990-4. PubMed ID: 22842225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonoscopy, imaging, and carcinoembryonic antigen: Comparison of guideline adherence to surveillance strategies in patients who underwent resection of colorectal cancer - A systematic review and meta-analysis.
    Dawood ZS; Hamad A; Moazzam Z; Alaimo L; Lima HA; Shaikh C; Munir MM; Endo Y; Pawlik TM
    Surg Oncol; 2023 Apr; 47():101910. PubMed ID: 36806402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to postresection colorectal cancer surveillance at National Cancer Institute-designated Comprehensive Cancer Centers.
    Kupfer SS; Lubner S; Coronel E; Pickhardt PJ; Tipping M; Graffy P; Keenan E; Ross E; Li T; Weinberg DS
    Cancer Med; 2018 Nov; 7(11):5351-5358. PubMed ID: 30338661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.
    Snyder RA; Hu CY; Cuddy A; Francescatti AB; Schumacher JR; Van Loon K; You YN; Kozower BD; Greenberg CC; Schrag D; Venook A; McKellar D; Winchester DP; Chang GJ;
    JAMA; 2018 May; 319(20):2104-2115. PubMed ID: 29800181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.
    Sanli Y; Kuyumcu S; Ozkan ZG; Kilic L; Balik E; Turkmen C; Has D; Isik G; Asoglu O; Kapran Y; Adalet I
    Ann Nucl Med; 2012 Aug; 26(7):551-8. PubMed ID: 22644560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET/CT superior to serum CEA in detection of colorectal cancer and its recurrence.
    Makis W; Kurzencwyg D; Hickeson M
    Clin Imaging; 2013; 37(6):1094-7. PubMed ID: 23993799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DIAGNOSTIC ROLE OF FLUORINE-18 (18F) FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY IN DETECTING RECURRENT DISEASE IN PATIENTS WITH COLORECTAL CANCER AND ELEVATED CARCINOEMBRYONIC ANTIGEN.
    Matovina E; Mihailović J; Nikoletić K; Srbovan D
    Med Pregl; 2015; 68(11-12):376-81. PubMed ID: 26939303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in surveillance for resected colorectal cancer, 2001-2009.
    Paulson EC; Veenstra CM; Vachani A; Ciunci CA; Epstein AJ
    Cancer; 2015 Oct; 121(19):3525-33. PubMed ID: 26079928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic antigen directed PET-CECT scanning for postoperative surveillance of colorectal cancer.
    Vallam KC; Guruchannabasavaiah B; Agrawal A; Rangarajan V; Ostwal V; Engineer R; Saklani A
    Colorectal Dis; 2017 Oct; 19(10):907-911. PubMed ID: 28444968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
    Ozkan E; Soydal C; Araz M; Kir KM; Ibis E
    Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [¹⁸F-FDG PET/CT. Its correlation with carcinoembryonic antigen in patients with colorectal carcinoma].
    Granados Rangel O; Estrada G; Altamirano J
    Gac Med Mex; 2014; 150(6):509-17. PubMed ID: 25375281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of post-treatment surveillance of early stage breast cancer in Texas.
    Parmar AD; Sheffield KM; Vargas GM; Han Y; Chao C; Riall TS
    Surgery; 2013 Aug; 154(2):214-25. PubMed ID: 23889950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations.
    Kyoto Y; Momose M; Kondo C; Itabashi M; Kameoka S; Kusakabe K
    Ann Nucl Med; 2010 Jun; 24(5):395-401. PubMed ID: 20364373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strict follow-up programme including CT and ¹⁸F-FDG-PET after curative surgery for colorectal cancer.
    Sørensen NF; Jensen AB; Wille-Jørgensen P; Friberg L; Rørdam L; Ingeman L; Hennild V
    Colorectal Dis; 2010 Oct; 12(10 Online):e224-8. PubMed ID: 20002699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing surveillance utilization and value in commercially insured patients with colorectal cancer.
    Suh K; Shankaran V; Bansal A
    Am J Manag Care; 2022 May; 28(5):e163-e169. PubMed ID: 35546589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.
    Shinkins B; Primrose JN; Pugh SA; Nicholson BD; Perera R; James T; Mant D
    Br J Surg; 2018 May; 105(6):658-662. PubMed ID: 29579327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.